Brief: Tela Bio Announces Sale Of Distribution Rights For Wound Care Product To Mimedx
March 20 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO ANNOUNCES SALE OF DISTRIBUTION RIGHTS FOR WOUND
CARE
PRODUCT TO MIMEDX
* TELA BIO INC - AS CONSIDERATION FOR SALE, MIMEDX WILL MAKE
AN
INITIAL $5.0 MILLION PAYMENT
* TELA BIO- MIMEDX WILL MAKE FUTURE PAYMENTS BETWEEN
MINIMUM OF
$3.0 MILLION AND $7.0 MILLION BASED ON NET SALES OF NIVIS OVER
NEXT TWO YEARS
Source text for Eikon: ID:nGNXbYWJ87
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsMiMedx Q1 sales fall 33%, miss estimates, cuts 2026 outlook
Brief: MiMedx Q1 Sales USD 58.991 Million Vs. IBES Estimate USD 65 Million
MiMedx beats Q4 sales estimates; announces $100 mln share buyback
Brief: MiMedx Q4 Sales USD 118.095 Million Vs. IBES Estimate USD 106.8 Million
MiMedx Q3 net sales beat estimates